Abstract:Objective:To detect the expression of multidrug resistance protein,PCNA and p53 in non-small cell lung cancer tissues,to investigate their relationship and the significance in patient with non-small cell lung cancer.Methods:Immunohistochemical staining was used to evaluated the expression of proliferating cell nuclear antigen(PCNA),p53,P170 protein,lung resistance protein(LRP),topoisomerase Ⅱ(TopoⅡ) and glutathione S-transferasen(GST-π) in cancer tissues from 70 patients with NSCLC.Results:The positive rate of PCNA,p53,P170,LRP,TopoⅡ and GST-π was 75.7%,60.0%,72.9%,67.1%,27.1% and 78.6% respectively.There was a correlation between the expression of PCNA and p53(r=0.354,P=0.003).There was significant difference in P170 expression with different N-stage and different TNM stage(P=0.016,0.018).There was also significant difference in LRP expression with different histology and TNM stage(P=0.000,0.048).There was also significant difference in GST-π expression with different sizes of primary tumors and TNM stage(P=0.002,0.008,0.028).Spearman analysis showed that there was a positive correlation between the expression of p53 and P170(P=0.003),and between p53 and GST-π(P=0.003).There was no correlation between the expression of PCNA and four multidrug resistance proteins(P>0.05).Conclusion:The expression of multidrug resistance protein(P170,GST-π) is significantly related to p53 protein,but PCNA.It is important to detect both p53 and multidrug resistance protein for predicting the multidrug resistance and prognosis in NSCLC.

Relationship between expression of multidrug resistance protein,PCNA and p53 and its significance in patients with non-small cell lung cancer